Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mirum Pharmaceuticals (MIRM) Assets Average: 2020-2025

Historic Assets Average for Mirum Pharmaceuticals (MIRM) over the last 6 years, with Sep 2025 value amounting to $755.5 million.

  • Mirum Pharmaceuticals' Assets Average rose 13.72% to $755.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $755.5 million, marking a year-over-year increase of 13.72%. This contributed to the annual value of $658.7 million for FY2024, which is 31.80% up from last year.
  • As of Q3 2025, Mirum Pharmaceuticals' Assets Average stood at $755.5 million, which was up 6.70% from $708.0 million recorded in Q2 2025.
  • In the past 5 years, Mirum Pharmaceuticals' Assets Average ranged from a high of $755.5 million in Q3 2025 and a low of $231.6 million during Q1 2021.
  • Its 3-year average for Assets Average is $610.1 million, with a median of $656.4 million in 2024.
  • Data for Mirum Pharmaceuticals' Assets Average shows a peak YoY skyrocketed of 89.18% (in 2024) over the last 5 years.
  • Over the past 5 years, Mirum Pharmaceuticals' Assets Average (Quarterly) stood at $264.9 million in 2021, then surged by 35.38% to $358.6 million in 2022, then soared by 80.87% to $648.6 million in 2023, then grew by 3.19% to $669.3 million in 2024, then increased by 13.72% to $755.5 million in 2025.
  • Its Assets Average stands at $755.5 million for Q3 2025, versus $708.0 million for Q2 2025 and $680.5 million for Q1 2025.